D'Orazio & Associates’s Hologic HOLX Stock Holding History

D'Orazio & Associates’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-224	Closed	-$17K	–	359
2021 Q3	$17K	Buy	+224	New	+$16.8K	﹤0.01%	434

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D'Orazio & Associates's HOLX Position: Q4 2021 in Review

D'Orazio & Associates sold out of Hologic (HOLX) in Q4 2021, closing a stake of 224 shares — an estimated $17K sold.

D'Orazio & Associates first reported a position in HOLX in Q3 2021 and held it in 1 quarter. The position peaked at $17K in Q3 2021. 679 funds tracked by Wall St. Rank hold HOLX as of Q4 2021.

D'Orazio & Associates reported no remaining Hologic position as of Q4 2021 after selling out during the quarter.
D'Orazio & Associates sold 224 Hologic shares in Q4 2021, an estimated $17K.
D'Orazio & Associates first reported a position in Hologic in Q3 2021 and held it in 1 quarter.
D'Orazio & Associates's Hologic position peaked at $17K in Q3 2021.
679 funds tracked by Wall St. Rank held Hologic as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.